Dapagliflozin in STEMI

Clinical trial NCT06174753 · RECRUITING

Trial details

NCT number: NCT06174753
Sponsor: Ottawa Heart Institute Research Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

ST Elevation Myocardial Infarction Myocardial Infarction

Start date: 2025-01-20
Primary completion: 2027-06-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.